28 September 2018 - Deborah Wilkes
GlaxoSmithKline's chief executive officer Emma Walmsley has captured the top spot in Fortune magazine's list of the Most Powerful Women in business outside the US.
Walmsley replaced Ana Botin, executive chair of Banco Santander, who had topped the list for four years in a row.
Noting that Walmsley had held the top job at GlaxoSmithKline for 17 months, Fortune said she had been "quick in bringing change to the 300 year-old company".
Fortune pointed out that GlaxoSmithKline had recently acquired Novartis' 36.5% stake in the consumer healthcare joint venture between the two companies for USD13.0 billion in cash (click here to read the News story).
The business magazine also noted that GlaxoSmithKline had recently announced a USD300 million deal with 23andMe, the privately-held consumer genetics and research company (click here to read the News story).
In addition, Fortune highlighted that Walmsley had "hired a high profile roster of talent from across the industry and beyond – poaching executives from AstraZeneca, Novartis, Pfizer, Walmart and HSBC among others – and putting them to work on her number one agenda item: reinvigorating drug development at the company".
Take out an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* Premium News Stories
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions
CLICK HERE TO FIND OUT MORE